APYX icon

Apyx Medical

37 hedge funds and large institutions have $19.3M invested in Apyx Medical in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

5% less funds holding

Funds holding: 39 → 37 (-2)

8.12% less ownership

Funds ownership: 31.56% → 23.44% (-8.1%)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

85% less capital inflows, than outflows

Capital inflows: $1.1M | Capital outflows: $7.15M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $41K

Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
6
Reduced
10
Closed
11
Calls
–
Puts
$41K
Net Calls
-$41K
Net Calls Change
-$41K

APYX Hedge Fund Activity: Q1 2017 in Review

37 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2017, worth a combined $19.3M — down 40% from $32.4M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new APYX positions and 11 closed out — a net gain of 2 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $315K. The largest seller was Cortina Asset Management, cutting an estimated $1.88M.

  • 37 institutional investors held Apyx Medical (APYX) as of Q1 2017, down from 39 in Q4 2016.
  • Funds reported $19.3M of Apyx Medical stock for Q1 2017, down 40% quarter-over-quarter.
  • 13 funds opened new Apyx Medical positions in Q1 2017 and 11 closed out, a net change of +2 holders.
  • The largest Apyx Medical buyer in Q1 2017 was BlackRock, an estimated $315K added.
  • The largest Apyx Medical seller in Q1 2017 was Cortina Asset Management, an estimated $1.88M sold.

Based on aggregated 13F filings for Q1 2017.